Michael Beck

1.8k total citations
67 papers, 1.3k citations indexed

About

Michael Beck is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Beck has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Radiology, Nuclear Medicine and Imaging, 14 papers in Molecular Biology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Beck's work include Radiopharmaceutical Chemistry and Applications (11 papers), Prostate Cancer Treatment and Research (8 papers) and Lysosomal Storage Disorders Research (7 papers). Michael Beck is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (11 papers), Prostate Cancer Treatment and Research (8 papers) and Lysosomal Storage Disorders Research (7 papers). Michael Beck collaborates with scholars based in Germany, Hungary and United States. Michael Beck's co-authors include Torsten Kuwert, Philipp Ritt, Michael Uder, Daniela Schmidt, Susanna Bunge, Cordula Steglich, Wim J. Kleijer, Andreas Gal, William A. Horton and Julie Sanford and has published in prestigious journals such as Nature, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Michael Beck

60 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Beck Germany 17 476 326 225 198 194 67 1.3k
Masahiro Terashima United States 23 431 0.9× 347 1.1× 58 0.3× 479 2.4× 194 1.0× 47 2.5k
Mark A. Green United States 26 1.1k 2.4× 389 1.2× 75 0.3× 361 1.8× 50 0.3× 56 2.0k
W. Maier‐Borst Germany 21 622 1.3× 371 1.1× 38 0.2× 443 2.2× 44 0.2× 83 1.7k
A. Marzotto Italy 22 88 0.2× 166 0.5× 136 0.6× 314 1.6× 155 0.8× 88 1.7k
Michael R. Ward Australia 31 476 1.0× 328 1.0× 24 0.1× 479 2.4× 111 0.6× 83 2.7k
Luke Higgins United States 13 69 0.1× 177 0.5× 138 0.6× 626 3.2× 183 0.9× 28 2.1k
Keiji Yamashita Japan 19 635 1.3× 415 1.3× 28 0.1× 187 0.9× 101 0.5× 70 1.6k
Xiyi Chen China 19 94 0.2× 179 0.5× 68 0.3× 363 1.8× 279 1.4× 44 1.8k
Hiroko Wada Japan 25 80 0.2× 93 0.3× 150 0.7× 634 3.2× 74 0.4× 153 2.2k
Alan B. Packard United States 26 1.1k 2.4× 449 1.4× 54 0.2× 679 3.4× 95 0.5× 85 2.6k

Countries citing papers authored by Michael Beck

Since Specialization
Citations

This map shows the geographic impact of Michael Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Beck more than expected).

Fields of papers citing papers by Michael Beck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Beck. The network helps show where Michael Beck may publish in the future.

Co-authorship network of co-authors of Michael Beck

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Beck. A scholar is included among the top collaborators of Michael Beck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Beck. Michael Beck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Atzinger, Armin, Koray Taşçılar, Arnd Kleyer, et al.. (2025). Synovial fibroblast activation occurs before the onset of rheumatoid arthritis and influences the risk of developing disease. RMD Open. 11(4). e005775–e005775.
2.
Singh, Usha, James D. Vasta, Michael Beck, et al.. (2025). A BRET biosensor for measuring uncompetitive engagement of PRMT5 complexes in cells. Nature Communications. 16(1). 10129–10129.
3.
Woelfle, Joachim, Michael Beck, Torsten Kuwert, et al.. (2025). Diagnosing Organ Involvement in Juvenile Systemic Sclerosis with 68Ga-FAPI-46 PET/CT. Journal of Nuclear Medicine Technology. 53(3). 248–251.
4.
5.
Richter, Daniel, et al.. (2024). Zufallsbefund Schilddrüsenknoten. HNO. 72(12). 908–918. 2 indexed citations
6.
Teske, Kelly A., Wenji Su, Cesear Corona, et al.. (2023). DELs enable the development of BRET probes for target engagement studies in cells. Cell chemical biology. 30(8). 987–998.e24. 6 indexed citations
7.
Smith, Jeffery L., Michael Beck, Jennifer Wilkinson, et al.. (2023). Development of Cell Permeable NanoBRET Probes for the Measurement of PLK1 Target Engagement in Live Cells. Molecules. 28(7). 2950–2950. 6 indexed citations
8.
Wullich, Bernd, Helge Täubert, Peter J. Goebell, et al.. (2023). Individualisierte Präzisionsmedizin. PubMed. 62(9). 879–888. 1 indexed citations
10.
Wuest, Wolfgang, Michael Brand, Daniela Schmidt, et al.. (2020). Individual Calculation of Effective Dose and Risk of Malignancy Based on Monte Carlo Simulations after Whole Body Computed Tomography. Scientific Reports. 10(1). 9475–9475. 14 indexed citations
11.
12.
Quick, Harald H., Michael Lell, Michael Uder, et al.. (2012). Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 40(1). 12–21. 110 indexed citations
13.
Penzel, Roland, Johannes Uhl, Jürgen Kopitz, et al.. (2001). Splice donor site mutation in the lysosomal neuraminidase gene causing exon skipping and complete loss of enzyme activity in a sialidosis patient. FEBS Letters. 501(2-3). 135–138. 10 indexed citations
14.
Bunge, Susanna, Wim J. Kleijer, Cordula Steglich, et al.. (1995). Mucopolysaccharidosis type I: Identification of 13 novel mutations of the α-L-iduronidase gene. Human Mutation. 6(1). 91–94. 40 indexed citations
15.
Becker, Konrad B., et al.. (1994). Proteoglycan synthesis by cultured human chondrocytes. Microscopy Research and Technique. 28(6). 520–526. 7 indexed citations
16.
Bunge, Susanna, Cordula Steglich, Peter Lorenz, et al.. (1994). Prenatal diagnosis and carrier detection in mucopolysaccharidosis type II by mutation analysis. A 47,xxy male heterozygous for a missense point mutation. Prenatal Diagnosis. 14(9). 777–780. 5 indexed citations
17.
Bunge, Susanna, Wim J. Kleijer, Cordula Steglich, et al.. (1994). Mucopolysaccharidosis type I: identification of 8 novel mutations and determination of the frequency of the two common α-L-iduronidase mutations (W402X and Q70X) among European patients. Human Molecular Genetics. 3(6). 861–866. 86 indexed citations
18.
Carubelli, Cecilia M, et al.. (1992). Influence of retinol on human chondrocytes in agarose culture. The Anatomical Record. 232(1). 52–59. 6 indexed citations
19.
Beck, Michael, et al.. (1989). Expression of the human chondrocyte phenotype in vitro. In Vitro Cellular & Developmental Biology - Plant. 25(7). 659–668. 147 indexed citations
20.
Beck, Michael. (1987). Critical survey of stability constants of cyano complexes. Pure and Applied Chemistry. 59(12). 1703–1720. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026